Treatment of bone complications in multiple myeloma patients
Multiple myeloma frequently leads to bone complications characterized by the presence of lytic defects with high incidence of pathologic fractures, hypercalcemia and osteoporosis. The basic cause of this effect lies in the ability of malignant plasmatic cells to stimulate osteoclasts which are cells...
Saved in:
| Main Author: | V. V. Ptushkin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/694 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteodestruction markers and quality of life parameters at pomegara (pamidronate) treatment in multiple myeloma patients with lytic bone lesions
by: V. V. Lunin, et al.
Published: (2022-11-01) -
Treatment of myeloma bone disease: When, how often, and for how long?
by: Michael Tveden Gundesen, et al.
Published: (2025-06-01) -
Prevention of bone metastases in breast cancer
by: L. M. Kogonia
Published: (2014-08-01) -
Differences in interactions with the bone microenvironment between solid tumors and multiple myeloma: pathogenetic aspects. Possibilities and effectiveness of osteomodifying agents in multiple myeloma
by: A. V. Snegovoy, et al.
Published: (2021-04-01) -
Dynamic changes in γδT cells and bone resorption markers after zoledronic acid in multiple myeloma: A prospective study
by: Chao-Hung Wei, et al.
Published: (2025-07-01)